Consequently, HSP90 stands as a pivotal enabler of oncogene addiction and a key player in facilitating the survival of cancer cells, and inhibition of HSP90 can lead to the degradation of these client proteins, making it a target for anticancer therapies.115. This evidence concerns the gene HSP90AB1 and cancer.